2026-01-20 - Analysis Report
**Company Overview**
Align Technology is a US-based medical device company that develops and manufactures dental care products.

**Market Comparison**

*   Ticker to review: ALGN
*   Company Name: Align Technology
*   Cumulative return of review stock: **-46.94%**
*   Cumulative return of comparison stock (S&P 500, VOO): **93.30%**
*   Divergence (max:174.90, min:-154.10, current:-140.20, relative divergence:4.20%)
*   This indicates that the stock performed significantly worse than the S&P 500 in the given time frame.

**Performance Metrics Table (2016-2025)**

| Year   | CAGR  | MDD | Alpha  | Beta | Cap(B) |
|--------|-------|-----|--------|------|--------|
| 2016-2018 | 47.0% | 48.8% | 42.0% | 1.5 | 15.2B |
| 2017-2019 | 69.0% | 50.2% | 51.0% | 1.6 | 20.2B |
| 2018-2020 | -23.0% | 50.2% | -44.0% | 1.5 | 38.7B |
| 2019-2021 | 16.0% | 45.1% | -28.0% | 1.5 | 47.6B |
| 2020-2022 | -108.0% | 75.2% | -106.0% | 1.5 | 15.3B |
| 2021-2023 | -138.0% | 75.2% | -139.0% | 1.7 | 19.9B |
| 2022-2024 | -79.0% | 64.3% | -99.0% | 1.7 | 15.1B |
| 2023-2025 | -25.0% | 57.2% | -87.0% | 1.5 | 11.3B |

This table provides the performance metrics (CAGR, MDD, Alpha, Beta, and market capitalization) for Align Technology over several time periods.

**Recent Stock Price Fluctuations**

*   5-day SMA: **$170.88**
*   20-day SMA: **$163.59**
*   60-day SMA: **$150.99**
*   Last market close: **$171.49**
*   Last market change (previous close): **$0.01**

These metrics indicate the recent stock price movement and its fluctuations compared to the moving averages.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis**

*   Market Risk Indicator (MRI): **0.80**
*   RSI: **74.10**
*   PPO: **0.16**
*   Recent relative divergence change: **0.10 (improving)**
*   7-day Rank change: **0 (flat)**
*   7-day Dynamic Expected Return change: **0.00 (flat)**
*   Expected Return (%): **-1656.90%**
*   Sharp rebound or sharp decline in the stock price is **not** a significant issue.

This analysis includes market risk, RSI (Relative Strength Index) and PPO (Percentage Price Oscillator) indicators, as well as the expected return based on recent market movements.

**News & Significant Events**
*   Assessing Align Technology (ALGN) Valuation After Recent Share Price Rebound And Modest Discount Signals - simplywall.st
*   Align Technology, Inc. (NASDAQ:ALGN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance
*   30 Canadian kids get Invisalign care through new Smiles4Canada effort - Stock Titan
*   Why Align Technology Stock Popped Today - The Motley Fool
*   3 Reasons to Avoid ALGN and 1 Stock to Buy Instead - FinancialContent
*   Align Technology Stock Forecast: Where Analysts See the Stock by 2027 - TIKR.com

These news articles and events highlight changes in market perception and future expectations for Align Technology.

**Analyst Opinions**

Anlyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
- Opinions: 15
- Target Price (avg/high/low): $180.47 / $220.00 / $150.00

Analysts recommend buying Align Technology with a median rating of "Buy" and a predicted target price.

**Recent Earnings Analysis**

| Date       | EPS | Revenue |
|------------|-----|---------|
| 2025-11-05 | 0.78 | $1.00B  |
| 2025-08-06 | 1.72 | $1.01B  |
| 2025-05-08 | 1.27 | $0.98B  |
| 2024-11-05 | 1.55 | $0.98B  |
| 2025-11-05 | 1.55 | $0.98B  |

EPS (Earnings Per Share) have shown variability, with a mix of positive and negative values. This trend could be an indicator of future growth.

**Revenue and Profitability Analysis**

| Quarter   | Revenue | Profit Margin |
|-----------|---------|---------------|
| 2025-09-30 | $1.00B  | 64.20%       |
| 2025-06-30 | $1.01B  | 69.94%       |
| 2025-03-31 | $0.98B  | 69.45%       |
| 2024-12-31 | $1.00B  | 70.03%       |
| 2024-09-30 | $0.98B  | 69.72%       |

Profit margins have demonstrated consistent growth throughout the given quarter, indicating that the company is generating more revenue without a significant decrease in profit margin.

**Capital and Profitability Analysis**

| Quarter  | Equity | ROE |
|----------|--------|-----|
| 2025-09-30 | $3.96B | 1.43% |
| 2025-06-30 | $3.91B | 3.18% |
| 2025-03-31 | $3.79B | 2.46% |
| 2024-12-31 | $3.85B | 2.69% |
| 2024-09-30 | $3.94B | 2.94% |

Equity and ROE have had varying trends in recent quarters, but have not seen a significant drop.

**Comprehensive Analysis**
Considering the market comparison, performance metrics table, recent stock price fluctuations, RSI and PPO analysis, news and significant events, analyst opinions, recent earnings, revenue and profitability analysis, capital and profitability analysis, we can conclude that:

*   The stock's performance has been poor in the given time frame when compared to the S&P 500.
*   Market risk is relatively low.
*   Recent sharp rebound in the stock price is not a significant issue.
*   Analysts recommend buying with a "Buy" rating and target price around $180.47.
*   EPS and revenue have shown some variability and inconsistent growth.
*   Profit margins have consistently grown during the given quarters.

Therefore, we cannot recommend any specific investment actions solely based on this report. Further analysis and due diligence are required for any investment decisions.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.